IRIS
CERULLO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.406
EU - Europa 1.894
NA - Nord America 1.843
SA - Sud America 344
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.745
SG - Singapore 1.284
RU - Federazione Russa 995
CN - Cina 497
IT - Italia 373
BR - Brasile 282
HK - Hong Kong 244
VN - Vietnam 184
FR - Francia 95
DE - Germania 92
NL - Olanda 81
IN - India 79
FI - Finlandia 56
CA - Canada 53
GB - Regno Unito 50
UA - Ucraina 34
SE - Svezia 32
MX - Messico 26
AR - Argentina 23
IE - Irlanda 22
ZA - Sudafrica 22
CI - Costa d'Avorio 19
KR - Corea 18
JP - Giappone 17
PL - Polonia 16
AT - Austria 14
BD - Bangladesh 13
ES - Italia 13
PK - Pakistan 10
EC - Ecuador 9
IQ - Iraq 9
TR - Turchia 8
CO - Colombia 7
ID - Indonesia 7
PY - Paraguay 7
MA - Marocco 6
UZ - Uzbekistan 6
CL - Cile 5
CZ - Repubblica Ceca 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
HN - Honduras 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
TT - Trinidad e Tobago 3
BZ - Belize 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GY - Guiana 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
TJ - Tagikistan 2
TN - Tunisia 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GM - Gambi 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
MK - Macedonia 1
NA - Namibia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PF - Polinesia Francese 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 6.556
Salva come PNG Salva come JPEG
Città #
Singapore 581
Hong Kong 244
Moscow 240
Chandler 162
Ashburn 149
Beijing 143
Santa Clara 142
Naples 112
Hefei 95
Millbury 81
Los Angeles 73
Ho Chi Minh City 64
Amsterdam 62
Boston 48
Napoli 42
Delhi 38
Hanoi 38
Princeton 38
Nanjing 34
Des Moines 32
Buffalo 31
Lawrence 30
New York 30
Munich 28
Ottawa 27
Redondo Beach 27
Seattle 26
Denver 23
Rome 22
Wilmington 22
Jacksonville 21
Helsinki 20
Nanchang 20
São Paulo 19
Mexico City 18
Dallas 17
San Jose 17
Brooklyn 15
Houston 15
Seoul 15
Stockholm 15
Phoenix 14
Shanghai 14
Tokyo 14
Montreal 13
Warsaw 13
Dong Ket 12
The Dalles 12
Turku 12
Chicago 11
Frankfurt am Main 11
Johannesburg 11
Orem 11
Shenyang 11
Atlanta 10
Chennai 10
Da Nang 10
Hebei 10
Jiaxing 10
Kochi 10
Nuremberg 10
Council Bluffs 9
Toronto 8
Bexley 7
Lappeenranta 7
Manchester 7
Milan 7
Poplar 7
Porto Alegre 7
San Francisco 7
Acerra 6
Ankara 6
Belo Horizonte 6
Dhaka 6
Haiphong 6
Kronberg 6
Tianjin 6
Baghdad 5
Boardman 5
Curitiba 5
London 5
Portici 5
Pune 5
Roubaix 5
Salvador 5
Tashkent 5
Vienna 5
Asunción 4
Biên Hòa 4
Changsha 4
Charlotte 4
Florence 4
Lissone 4
Mumbai 4
Nembro 4
Ninh Bình 4
Recife 4
Rio de Janeiro 4
Secaucus 4
Sesto Fiorentino 4
Totale 3.315
Salva come PNG Salva come JPEG
Nome #
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 209
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy 148
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 140
Ischemic Neoangiogenesis Enhanced by {beta}2-Adrenergic Receptor Overexpression. A Novel Role for the Endothelial Adrenergic System. 138
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/ double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumour activity 137
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy. 137
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 132
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 131
AKT participates in endothelial dysfunction in hypertension. 115
PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice 111
Oncolytic adenoviruses for cancer therapy 108
Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin-Platinum(II) Complex 108
Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice 108
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 107
Solid phase synthesis of new dinuclear platinum complexes having a modified nucleoside as ligand. 103
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 102
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumor activity 100
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 99
Viral molecular mimicry influences the antitumor immune response in murine and human melanoma 97
PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile 95
Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells 94
Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. 93
Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system. 93
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 93
Discovery of a new PCC-mediated stereoselective oxidative spiroketalization process. An access to a new type of poly-THF spiroketal compound displaying anticancer activity 90
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017) 89
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 89
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors 89
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses 87
Artificially cloaked viral nanovaccine for cancer immunotherapy 87
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor 87
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors 85
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification 85
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors 84
Application of array-comparative genomic hybridization analysis in immune-virotherapy approach 84
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 83
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer 81
The evolution of adenoviral vectors through genetic and chemical surface modifications 81
Generation of a helper-dependent adenoviral vector by homologous recombination 80
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 79
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 79
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans 78
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 74
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 74
Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy 74
Low-dose Decitabine enhances the efficacy of viral cancer vaccines for immunotherapy 73
Uncovering the tumor antigen landscape: What to know about the discovery process 72
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors 71
Toll-like Receptor 9 Triggers an Innate Immune Response to Helper-dependent Adenoviral Vectors. 71
Short-Term Correction of Arginase Deficiency in a Neonatal Murine Model with a Helper-Dependent Adenoviral Vector. 70
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy 70
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site 70
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin 70
PNA-functionalized adenoviral vectors as new tool for gene modulation in anti-cancer treatment 67
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery 67
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy 67
MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to Helper-dependent adenovirus. 63
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors 63
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy 58
Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver 56
Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus 53
Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus 52
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients 52
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus 52
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 51
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance 50
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus 47
Design and application of oncolytic viruses for cancer immunotherapy 47
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction 46
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice 45
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses 45
Thiol-ene surface modifications for microchip electrophoresis based interaction assays 44
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy 44
Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus 43
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo 43
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging 42
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids 42
GMCSF-armed vaccinia virus induces an antitumor immune response 40
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients 39
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform 39
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment 38
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus 38
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 38
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: Assessment of safety and immunologic responses in patients 36
Pathogens: Our Allies against Cancer? 36
Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions 35
Totale 6.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 5 20 13 5 9 16
2021/2022348 6 0 0 7 1 11 3 12 48 11 78 171
2022/2023486 71 47 11 20 50 44 1 54 71 70 25 22
2023/2024407 31 76 52 19 15 36 19 58 3 4 61 33
2024/20252.320 135 122 10 15 66 122 247 147 143 280 845 188
2025/20262.632 469 321 449 418 765 189 21 0 0 0 0 0
Totale 6.682